8-K: Arteris Reports Record Q3, Exceeds $100M RPO

Arteris, Inc. announced strong third-quarter 2025 financial results, including record Annual Contract Value plus royalties and Remaining Performance Obligations, while providing updated full-year guidance.

Summary

• Third quarter 2025 revenue reached $17.4 million, an 18% increase year-over-year.
• Annual Contract Value (ACV) plus royalties hit a record $74.9 million, up 24% year-over-year.
• Remaining Performance Obligations (RPO) achieved a record $104.7 million, marking a 34% year-over-year increase and exceeding $100 million for the first time.
• The company reported a GAAP operating loss of $8.7 million, compared to $7.9 million in Q3 2024.
• Non-GAAP operating loss was $3.5 million, compared to $3.3 million in Q3 2024.
• GAAP net loss for the quarter was $9.0 million, or $0.21 per share.
• Non-GAAP net loss was $3.8 million, or $0.09 per share.
• Non-GAAP free cash flow was positive $2.5 million, representing 14% of revenue.
• Updated full-year 2025 guidance includes revenue between $68.8 million and $69.2 million, Non-GAAP operating loss between $12.5 million and $13.5 million, and free cash flow between $2.5 million and $5.5 million.

Sentiment

Score: 7

Explanation: The sentiment is positive due to strong growth in key business metrics (ACV, RPO, Revenue) and positive free cash flow, indicating operational strength and market traction in high-growth areas like AI. However, increasing GAAP and Non-GAAP net losses and operating losses temper the overall sentiment, suggesting profitability remains a challenge despite revenue growth.

Positives

• Achieved record Annual Contract Value (ACV) plus royalties of $74.9 million, representing a 24% year-over-year increase.
• Remaining Performance Obligations (RPO) reached a record $104.7 million, up 34% year-over-year and surpassing $100 million for the first time in company history.
• Revenue grew by 18% year-over-year to $17.4 million in the third quarter.
• Generated positive Non-GAAP free cash flow of $2.5 million, equivalent to 14% of revenue.
• Expanded customer engagements, including Altera expanding its use of existing IP and licensing new products, AMD ordering additional licenses, and new FlexGen customers in automotive (Dream Chip, leading OEM) and aerospace (NanoXplore).
• Secured a license with 2V Systems for Ncore and FlexNoC interconnect for a high-bandwidth IO Hub chiplet.
• Expanded collaboration with Alibaba Damo Academy to improve integration and optimize performance for CPU cores.
• Joined the Ultra Accelerator Link Consortium (UALink), indicating a key role in AI data movement for chiplets and SoCs.

Negatives

• GAAP operating loss increased to $8.7 million in Q3 2025 from $7.9 million in Q3 2024.
• Non-GAAP operating loss increased to $3.5 million in Q3 2025 from $3.3 million in Q3 2024.
• GAAP net loss increased to $9.0 million in Q3 2025 from $7.687 million in Q3 2024.
• Non-GAAP net loss increased to $3.8 million in Q3 2025 from $3.080 million in Q3 2024.
• Accumulated deficit worsened to $(163.1) million as of September 30, 2025, from $(136.9) million as of December 31, 2024.
• Total stockholders' deficit increased to $(11.4) million as of September 30, 2025, from $(1.2) million as of December 31, 2024.

Risks

• Significant competition from larger companies and third-party providers.
• History of net losses.
• Uncertainty regarding semiconductor companies incorporating solutions into their end products and the growth and economic stability of target end markets (automotive, enterprise computing, communications, consumer electronics, industrial).
• Ability to attract new customers and the extent to which existing customers renew subscriptions.
• The ability of customer end products to achieve market acceptance or growth.
• Ability to sustain or grow licensing revenue.
• Ability and cost to successfully execute on research and development efforts.
• Occurrence of product errors or defects in solutions.
• Failure to offer high-quality support.
• Impact of macro-economic conditions, including tariffs, on the company, its customers, and their end product markets.
• Effects of geopolitical conflicts, such as the military conflict between Russia and Ukraine and the ongoing conflict in the Middle East.
• Exposure to regulatory, operational, financial, and political risks due to dependence on international customers and operations.
• Ability to protect proprietary technology and inventions through patents and other intellectual property rights.
• Potential liabilities or fines resulting from government regulation, including import, export, and economic sanctions laws.
• Occurrence of a disruption in networks or a security breach.
• Risks associated with doing business in China, including changes to trade relations between the United States and China.

Future Outlook

Arteris remains confident in its long-term growth opportunity, driven by its expanding product portfolio, growing partnerships, and increasing customer demand across high-growth markets such as AI, autonomous driving, and advanced communications. The company believes its deep expertise and proven technology uniquely position it to capture transformative opportunities as AI adoption accelerates and system complexity grows with the rise of chiplet-based, multi-die SoC architectures.

Management Comments

• "In the third quarter of 2025, we achieved another record with Annual Contract Value plus royalties of $74.9 million, up 24% year-over-year. In addition, we exited the quarter with $104.7 million in Remaining Performance Obligations, up 34% year-over-year and exceeding $100.0 million for the first time in our history." K. Charles Janac, President and CEO of Arteris.
• "Looking ahead, we remain confident in Arteris long-term growth opportunity, driven by our growing product portfolio, expanding partnerships and increasing customer demand across high-growth markets such as AI, autonomous driving, and advanced communications." K. Charles Janac, President and CEO of Arteris.
• "As AI adoption accelerates and system complexity grows with the rise of chiplet-based, multi-die SoC architectures, we believe Arteris deep expertise and proven technology uniquely position us to capture these transformative opportunities." K. Charles Janac, President and CEO of Arteris.

Industry Context

Arteris operates in the critical semiconductor IP sector, providing network-on-chip (NoC) interconnect IP and SoC integration automation software. The company's strong performance and strategic focus align with broader industry trends, particularly the accelerating demand for advanced semiconductor solutions in high-growth markets like AI, autonomous driving, and advanced communications. The increasing complexity of chiplet-based, multi-die SoC architectures underscores the growing need for Arteris's specialized technology. Its expanded collaborations with industry leaders like Altera, AMD, and Alibaba Damo Academy, along with its participation in the Ultra Accelerator Link Consortium (UALink), demonstrate its relevance and positioning within the evolving semiconductor ecosystem, especially concerning efficient data movement in AI-driven designs.

Comparison to Industry Standards

• NA

Stakeholder Impact

• Shareholders: The strong growth in ACV, RPO, and revenue, coupled with strategic positioning in high-growth markets like AI and autonomous driving, could positively impact shareholder value. However, increasing net and operating losses may raise concerns about profitability.
• Customers: Expanded product offerings and collaborations (e.g., Altera, AMD, Alibaba Damo Academy) suggest continued innovation and enhanced support for customer SoC designs, potentially leading to stronger partnerships and product integration.
• Employees: Continued company growth and strategic initiatives in cutting-edge technologies may indicate stability and opportunities for professional development within the organization.

Next Steps

• Host a conference call on November 4, 2025, at 4:30 PM ET to review third quarter 2025 financial results and discuss the financial outlook.
• File the Quarterly Report on Form 10-Q for the quarter ended September 30, 2025, with the Securities and Exchange Commission (SEC) on November 4, 2025.
• Continue to pursue long-term growth opportunities driven by product portfolio expansion, expanding partnerships, and increasing customer demand across high-growth markets such as AI, autonomous driving, and advanced communications.

Key Dates

Recommendation

Arteris demonstrates robust top-line growth with record ACV, RPO, and strong revenue increases, indicating healthy market demand and strategic positioning in critical high-growth sectors like AI and autonomous driving. The achievement of positive Non-GAAP free cash flow is also a positive sign for liquidity. However, the company continues to report increasing GAAP and Non-GAAP operating and net losses. While growth is strong, the path to sustained profitability remains unclear. Therefore, a 'hold' recommendation is appropriate, advising investors to monitor future filings for signs of improved profitability alongside continued revenue expansion and market penetration.

Keywords

Semiconductor IP, System-on-Chip, SoC, Network-on-Chip, NoC, AI, Autonomous Driving, Chiplet, Multi-die, FlexGen, Ncore, Magillem, UALink, Financial Results, Q3 2025, Guidance, Arteris